Veil Therapeutics
Durham, United States (US) · Health and Medical
We built this page from public sources.
Do you work at Veil Therapeutics?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Veil Therapeutics is a Health and Medical company based in Durham, United States (US), with 2-10 employees. Veil Therapeutics's profile is verified on Enterprise League.
Overview
Veil Therapeutics is a Durham, North Carolina-based biotechnology company pioneering stealth biologics. We’re developing a revolutionary platform, the Veil Platform, that makes biologics undetectable by the immune system, enabling long-lasting and effective treatments.
Our core technology, built upon advanced polymer engineering, fundamentally alters the structure of PEG-based polymers into small, discrete units, significantly reducing their immunogenicity. This approach provides enhanced pharmacokinetic properties, stability, and shielding without triggering an immune response – a critical advancement for protein and peptide therapeutics.
Founded by Dr. Ashutosh Chilkoti and led by CEO Ryan Hallett, Veil Therapeutics is comprised of a team of experienced scientists and entrepreneurs dedicated to transforming drug delivery. We are currently focused on our lead program, VTx-101, a polymer-conjugated uricase for the treatment of chronic gout, and are open to development partnerships focused on lipid nanoparticles, liposomes & aptamer delivery.
Our core technology, built upon advanced polymer engineering, fundamentally alters the structure of PEG-based polymers into small, discrete units, significantly reducing their immunogenicity. This approach provides enhanced pharmacokinetic properties, stability, and shielding without triggering an immune response – a critical advancement for protein and peptide therapeutics.
Founded by Dr. Ashutosh Chilkoti and led by CEO Ryan Hallett, Veil Therapeutics is comprised of a team of experienced scientists and entrepreneurs dedicated to transforming drug delivery. We are currently focused on our lead program, VTx-101, a polymer-conjugated uricase for the treatment of chronic gout, and are open to development partnerships focused on lipid nanoparticles, liposomes & aptamer delivery.
Contact Details
contact@veiltherapeutics.com
Durham, United States (US), 4260 Bennett Memorial Rd
Company Type
Private Limited Company
Employees
2-10
Categories
Companies teams usually look at after Veil Therapeutics
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.